A study[1] being published in the upcoming issue of the Journal of Alzheimer’s Disease, and e-published ahead of print by the National Institute of Health, has found that cannabis oil is a safe and effective treatment option for Alzheimer’s disease, which affects over 5 million U.S. citizens.
According to researchers, the objective of the study was; “To measure efficacy and safety of medical cannabis oil (MCO) containing THC as an add-on to pharmacotherapy, in relieving behavioral and psychological symptoms of dementia (BPSD).”
Participants of the study saw a “significant decrease” of: “Dlusions, agitation/aggression, irritability, apathy, and sleep and caregiver distress.”
The study concludes that; “Adding MCO [medical cannabis oil] to AD [Alzheimer’s disease] patients’ pharmacotherapy is safe and a promising treatment option.”
The full study can be found by clicking here[2].
References
- ^ A study (www.ncbi.nlm.nih.gov)
- ^ clicking here (www.ncbi.nlm.nih.gov)
Latest
Coronavirus Strikes Massachusetts Cannabis Company Employees
Reassessing the Essential: Cannabis in the Time of a Pandemic
5 Reasons To Try Aspen Valley CBG Flower (30% Off)
High Times Cannabis Cups Go Virtual In Wake Of Coronavirus Pandemic
Drug Enforcement Administration Proposes Plan To Expand Cannabis Research
Ghana Legalizes Cannabis For Medicinal And Industrial Uses
The cheapest legal weed in Canada: Discover these cannabis ‘value brands’
Cannabis and coronavirus: Here’s what you need to know
cannabis designs
The Best Of
WHO Rules CBD Should Not Be a Scheduled Drug
Dr Cristina Sanchez PhD video interview on medical marijuana and cancer
Biochemist Dennis Hill interview; Cannabis oil as a cure for cancer.
The unofficial World Record holder for cannabis smoking part 1
Legalise cannabis for medical use: top professor
